000			01492 a2200385 4500
005			20250516140058.0
264		0	_c20130916
008			201309s 0 0 eng d
022			_a1760-4788
024	7		_a10.1007/s12603-012-0431-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aDacks, P A
245	0	0	_aCurrent evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease. _h[electronic resource]
260			_bThe journal of nutrition, health & aging _cMar 2013
300			_a240-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAging _xdrug effects
650	0	4	_aAlzheimer Disease _xprevention & control
650	0	4	_aApolipoprotein E4 _xblood
650	0	4	_aBiological Availability
650	0	4	_aClinical Trials as Topic
650	0	4	_aCognition Disorders _xprevention & control
650	0	4	_aDepression _xdrug therapy
650	0	4	_aDiet
650	0	4	_aDietary Supplements
650	0	4	_aDocosahexaenoic Acids _xadministration & dosage
650	0	4	_aEicosapentaenoic Acid _xadministration & dosage
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aMeta-Analysis as Topic
700	1		_aShineman, D W
700	1		_aFillit, H M
773	0		_tThe journal of nutrition, health & aging _gvol. 17 _gno. 3 _gp. 240-51
856	4	0	_uhttps://doi.org/10.1007/s12603-012-0431-3 _zAvailable from publisher's website
999			_c22552629 _d22552629